• Korean
Cover Image

Greece Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018

Abstract

Summary

"Greece Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018", a new report by Global Markets Direct, provides key market data on the Greece Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within six market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Markets Direct's team of industry experts.

Scope

  • Market size and company share data for Neurology Devices market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery.
  • Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within six market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.
  • 2011 company shares and distribution shares data for each of the six market categories.
  • Global corporate-level profiles of key companies operating within the Greece Neurology Devicesmarket.
  • Key players covered include Medtronic, Inc., Stryker Corporation, St. Jude Medical, Inc., DePuy, Inc., Natus Medical Incorporated, Cadwell Laboratories, Inc. and others.

Reasons to buy

  • Develop business strategies by identifying the key market categories and segments poised for strong growth.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the Greece Neurology Devices competitive landscape.
  • Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2. Introduction

  • 2.1 What is This Report About?

3. Neurology Devices In Greece

  • 3.1 Neurology Devices, Greece, Overall Revenue ($m), USD Constant, 2004-2018
  • 3.2 Neurology Devices, Greece, Company Share (2010-2011)

4. CSF Management In Greece

  • 4.1 CSF Management Overall Revenue, (2004-2018)
  • 4.2 CSF Management Overall Volume (2004-2018)
  • 4.3 CSF Management Average Price (2004-2018)
  • 4.4 CSF Management Distribution Share (2010-2011)
  • 4.5 CSF Management, Greece, Company Share (2010-2011)

5. Interventional Neurology In Greece

  • 5.1 Interventional Neurology Overall Revenue, (2004-2018)
    • 5.1.1 Embolic Systems Revenue (2004-2018)
    • 5.1.2 Navigational Systems Revenue (2004-2018)
  • 5.2 Interventional Neurology Overall Volume (2004-2018)
    • 5.2.1 Embolic Systems Volume (2004-2018)
    • 5.2.2 Navigational Systems Volume (2004-2018)
  • 5.3 Interventional Neurology Average Price (2004-2018)
  • 5.4 Interventional Neurology Distribution Share (2010-2011)
  • 5.5 Interventional Neurology, Greece, Company Share (2010-2011)

6. Neurological Diagnostic Equipment In Greece

  • 6.1 Neurological Diagnostic Equipment Overall Revenue, (2004-2018)
  • 6.2 Neurological Diagnostic Equipment Overall Volume (2004-2018)
  • 6.3 Neurological Diagnostic Equipment Average Price (2004-2018)
  • 6.4 Neurological Diagnostic Equipment Distribution Share (2010-2011)
  • 6.5 Neurological Diagnostic Equipment, Greece, Company Share (2010-2011)

7. Neurostimulation Devices In Greece

  • 7.1 Neurostimulation Devices Overall Revenue, (2004-2018)
  • 7.2 Neurostimulation Devices Overall Volume (2004-2018)
  • 7.3 Neurostimulation Devices Average Price (2004-2018)
  • 7.4 Neurostimulation Devices Distribution Share (2010-2011)
  • 7.5 Neurostimulation Devices, Greece, Company Share (2010-2011)

8. Neurosurgical Products In Greece

  • 8.1 Neurosurgical Products Overall Revenue, (2004-2018)
  • 8.2 Neurosurgical Products Overall Volume (2004-2018)
  • 8.3 Neurosurgical Products Average Price (2004-2018)
  • 8.4 Neurosurgical Products Distribution Share (2010-2011)
  • 8.5 Neurosurgical Products, Greece, Company Share (2010-2011)

9. Radiosurgery In Greece

  • 9.1 Radiosurgery Overall Revenue, (2004-2011)
  • 9.2 Radiosurgery Overall Volume (2004-2011)
  • 9.3 Radiosurgery Average Price (2004-2011)

10. Overview of Key Companies in Greece Neurology Devices Market

  • 10.1 Medtronic, Inc.
    • 10.1.1 Company Overview
  • 10.2 Boston Scientific Corporation
    • 10.2.1 Company Overview
  • 10.3 St. Jude Medical, Inc.
    • 10.3.1 Company Overview
  • 10.4 B. Braun Melsungen AG
    • 10.4.1 Company Overview
  • 10.5 Cadwell Laboratories, Inc.
    • 10.5.1 Company Overview
  • 10.6 Natus Medical Incorporated
    • 10.6.1 Company Overview
  • 10.7 DePuy, Inc.
    • 10.7.1 Company Overview
  • 10.8 Terumo Corporation
    • 10.8.1 Company Overview
  • 10.9 CareFusion Corporation
    • 10.9.1 Company Overview
  • 10.10 Integra LifeSciences Holdings Corporation
    • 10.10.1 Company Overview
  • 10.11 Micromed S.p.A
    • 10.11.1 Company Overview
  • 10.12 Nihon Kohden Corporation
    • 10.12.1 Company Overview
  • 10.13 Cyberonics, Inc.
    • 10.13.1 Company Overview
  • 10.14 Christoph Miethke GmbH & Co. KG
    • 10.14.1 Company Overview
  • 10.15 KARL STORZ GmbH & Co. KG
    • 10.15.1 Company Overview
  • 10.16 Stryker Corporation
    • 10.16.1 Company Overview
  • 10.17 Sophysa S.A.
    • 10.17.1 Company Overview
  • 10.18 Covidien plc
    • 10.18.1 Company Overview

11. Appendix

  • 11.1 Global Markets Direct Research Methodology
  • 11.2 Definitions of Markets Covered in the Report
    • 11.2.1 Neurology Devices
  • 11.3 Secondary Research
  • 11.4 Primary Research
  • 11.5 Models
  • 11.6 Forecasts
  • 11.7 Expert Panel Validation
  • 11.8 Currency Conversion
  • 11.9 Contact Us
  • 11.10 Disclaimer

List of Tables

  • Table 1: Neurology Devices, Greece, Overall Revenue ($m), USD Constant, 2004-2018
  • Table 2: Neurology Devices, Greece, Overall Revenue ($m), USD Constant, Historic, 2004-2011
  • Table 3: Neurology Devices, Greece, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
  • Table 4: Neurology Devices, Greece, Company Share by Revenue ($m), USD Constant, 2010-2011
  • Table 5: CSF Management, Greece, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
  • Table 6: CSF Management, Greece, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
  • Table 7: CSF Management, Greece, Volume (Units) by Segment, Historic, 2004-2011
  • Table 8: CSF Management, Greece, Volume (Units) by Segment, Forecast, 2011-2018
  • Table 9: CSF Management, Greece, Average Price ($), Historic, 2004-2011
  • Table 10: CSF Management, Greece, Average Price ($), Forecast, 2011-2018
  • Table 11: CSF Management, Greece, Distribution Share by Revenue ($m), USD Constant, 2010-2011
  • Table 12: CSF Management, Greece, Company Share by Revenue ($m), USD Constant, 2010-2011
  • Table 13: Interventional Neurology, Greece, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
  • Table 14: Interventional Neurology, Greece, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
  • Table 15: Embolic Systems, Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Table 16: Embolic Systems, Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Table 17: Navigational Systems, Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Table 18: Navigational Systems, Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Table 19: Interventional Neurology, Greece, Volume (Units) by Segment, Historic, 2004-2011
  • Table 20: Interventional Neurology, Greece, Volume (Units) by Segment, Forecast, 2011-2018
  • Table 21: Embolic Systems, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Table 22: Embolic Systems, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Table 23: Navigational Systems, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Table 24: Navigational Systems, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Table 25: Interventional Neurology, Greece, Average Price ($), Historic, 2004-2011
  • Table 26: Interventional Neurology, Greece, Average Price ($), Forecast, 2011-2018
  • Table 27: Interventional Neurology, Greece, Distribution Share by Revenue ($m), USD Constant, 2010-2011
  • Table 28: Interventional Neurology, Greece, Company Share by Revenue ($m), USD Constant, 2010-2011
  • Table 29: Neurological Diagnostic Equipment, Greece, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
  • Table 30: Neurological Diagnostic Equipment, Greece, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
  • Table 31: Neurological Diagnostic Equipment, Greece, Volume (Units) by Segment, Historic, 2004-2011
  • Table 32: Neurological Diagnostic Equipment, Greece, Volume (Units) by Segment, Forecast, 2011-2018
  • Table 33: Neurological Diagnostic Equipment, Greece, Average Price ($), Historic, 2004-2011
  • Table 34: Neurological Diagnostic Equipment, Greece, Average Price ($), Forecast, 2011-2018
  • Table 35: Neurological Diagnostic Equipment, Greece, Distribution Share by Revenue ($m), USD Constant, 2010-2011
  • Table 36: Neurological Diagnostic Equipment, Greece, Company Share by Revenue ($m), USD Constant, 2010-2011
  • Table 37: Neurostimulation Devices, Greece, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
  • Table 38: Neurostimulation Devices, Greece, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
  • Table 39: Neurostimulation Devices, Greece, Volume (Units) by Segment, Historic, 2004-2011
  • Table 40: Neurostimulation Devices, Greece, Volume (Units) by Segment, Forecast, 2011-2018
  • Table 41: Neurostimulation Devices, Greece, Average Price ($), Historic, 2004-2011
  • Table 42: Neurostimulation Devices, Greece, Average Price ($), Forecast, 2011-2018
  • Table 43: Neurostimulation Devices, Greece, Distribution Share by Revenue ($m), USD Constant, 2010-2011
  • Table 44: Neurostimulation Devices, Greece, Company Share by Revenue ($m), USD Constant, 2010-2011
  • Table 45: Neurosurgical Products, Greece, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
  • Table 46: Neurosurgical Products, Greece, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
  • Table 47: Neurosurgical Products, Greece, Volume (Units) by Segment, Historic, 2004-2011
  • Table 48: Neurosurgical Products, Greece, Volume (Units) by Segment, Forecast, 2011-2018
  • Table 49: Neurosurgical Products, Greece, Average Price ($), Historic, 2004-2011
  • Table 50: Neurosurgical Products, Greece, Average Price ($), Forecast, 2011-2018
  • Table 51: Neurosurgical Products, Greece, Distribution Share by Revenue ($m), USD Constant, 2010-2011
  • Table 52: Neurosurgical Products, Greece, Company Share by Revenue ($m), USD Constant, 2010-2011
  • Table 53: Radiosurgery, Greece, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
  • Table 54: Radiosurgery, Greece, Volume (Units) by Segment, Historic, 2004-2011
  • Table 55: Radiosurgery, Greece, Average Price ($), Historic, 2004-2011

List of Figures

  • Figure 1: Neurology Devices, Greece, Overall Revenue ($m), USD Constant, 2004-2018
  • Figure 2: Neurology Devices, Greece, Overall Revenue ($m), USD Constant, Historic, 2004-2011
  • Figure 3: Neurology Devices, Greece, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
  • Figure 4: Neurology Devices, Greece, Company Share (%), 2011
  • Figure 5: CSF Management, Greece, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
  • Figure 6: CSF Management, Greece, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
  • Figure 7: CSF Management, Greece, Volume (Units) by Segment, Historic, 2004-2011
  • Figure 8: CSF Management, Greece, Volume (Units) by Segment, Forecast, 2011-2018
  • Figure 9: CSF Management, Greece, Company Share (%), 2011
  • Figure 10: Interventional Neurology, Greece, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
  • Figure 11: Interventional Neurology, Greece, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
  • Figure 12: Embolic Systems, Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Figure 13: Embolic Systems, Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Figure 14: Navigational Systems, Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
  • Figure 15: Navigational Systems, Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
  • Figure 16: Interventional Neurology, Greece, Volume (Units) by Segment, Historic, 2004-2011
  • Figure 17: Interventional Neurology, Greece, Volume (Units) by Segment, Forecast, 2011-2018
  • Figure 18: Embolic Systems, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Figure 19: Embolic Systems, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Figure 20: Navigational Systems, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011
  • Figure 21: Navigational Systems, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018
  • Figure 22: Interventional Neurology, Greece, Company Share (%), 2011
  • Figure 23: Neurological Diagnostic Equipment, Greece, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
  • Figure 24: Neurological Diagnostic Equipment, Greece, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
  • Figure 25: Neurological Diagnostic Equipment, Greece, Volume (Units) by Segment, Historic, 2004-2011
  • Figure 26: Neurological Diagnostic Equipment, Greece, Volume (Units) by Segment, Forecast, 2011-2018
  • Figure 27: Neurological Diagnostic Equipment, Greece, Company Share (%), 2011
  • Figure 28: Neurostimulation Devices, Greece, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
  • Figure 29: Neurostimulation Devices, Greece, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
  • Figure 30: Neurostimulation Devices, Greece, Volume (Units) by Segment, Historic, 2004-2011
  • Figure 31: Neurostimulation Devices, Greece, Volume (Units) by Segment, Forecast, 2011-2018
  • Figure 32: Neurostimulation Devices, Greece, Company Share (%), 2011
  • Figure 33: Neurosurgical Products, Greece, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
  • Figure 34: Neurosurgical Products, Greece, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
  • Figure 35: Neurosurgical Products, Greece, Volume (Units) by Segment, Historic, 2004-2011
  • Figure 36: Neurosurgical Products, Greece, Volume (Units) by Segment, Forecast, 2011-2018
  • Figure 37: Neurosurgical Products, Greece, Company Share (%), 2011
  • Figure 38: Radiosurgery, Greece, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
  • Figure 39: Radiosurgery, Greece, Volume (Units) by Segment, Historic, 2004-2011
  • Figure 40: Global Markets Direct Methodology
Show More
Pricing